Related references
Note: Only part of the references are listed.
Article
Public, Environmental & Occupational Health
Mark D. M. Davis et al.
Summary: This paper analyzes general public narratives on antimicrobial resistance (AMR) using an assemblage lens. The study finds that public awareness and action on AMR are lacking, partly due to public health messages overlooking the social, affective, and moral dimensions of infection care.
Article
Infectious Diseases
Tilman Schultze et al.
Summary: Since the war in Ukraine began in February 2022, Ukrainians have been seeking refuge in other European countries. A study was conducted to investigate the prevalence and molecular epidemiology of multidrug-resistant Gram-negative bacteria and meticillin-resistant Staphylococcus aureus in Ukrainian patients admitted to a hospital in Frankfurt, Germany. The study found a high prevalence of multidrug-resistant bacteria in Ukrainian patients, particularly those with war-related injuries, and recommended infection control strategies to prevent the spread of hypervirulent isolates.
Review
Infectious Diseases
Yulong Chi et al.
Summary: This study evaluated the clinical efficacy and safety of ceftolozane-tazobactam in treating Gram-negative bacterial infections. The results showed that ceftolozane-tazobactam had excellent clinical and microbiological efficacy in treating these infections. The safety profile of ceftolozane-tazobactam was comparable to other antimicrobials.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
(2023)
Article
Infectious Diseases
Michelle E. Coen et al.
Summary: This study examined changes in reported symptoms and characteristics of gonorrhea cases during the COVID-19 pandemic compared to the pre-pandemic period. The findings showed a decrease in cases reported by sexual health clinics and an increase in cases reported by emergency departments/urgent care centers during the pandemic. The study also found that cases with insurance, living with human immunodeficiency virus, or with recent gonorrhea history were more frequently reported during the pandemic.
SEXUALLY TRANSMITTED DISEASES
(2023)
Article
Respiratory System
Alessandra Iacovelli et al.
Summary: This study aims to assess the prevalence of co-infections and superinfections in a respiratory COVID-19 sub-intensive care unit, evaluate the risk factors for the development of superinfections, and assess the impact of superinfections on in-hospital mortality. The study found that superinfections were common in the respiratory sub-intensive care unit and were an independent predictor of mortality.
BMC PULMONARY MEDICINE
(2023)
Article
Roberta Magnano San Lio et al.
International Journal of Environmental Research and Public Health
(2023)
Article
Health Care Sciences & Services
Jaesh Naik et al.
Summary: This article examines the economic value of the new antibiotic imipenem/cilastatin/relebactam compared to piperacillin/tazobactam in the treatment of hospital-acquired pneumonia. The study finds that imipenem/cilastatin/relebactam can provide more health benefits at a higher cost. Therefore, it could be a cost-effective option for treating hospital-acquired pneumonia.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH
(2023)
Editorial Material
Microbiology
Francesca Paola Nocera et al.
Article
Infectious Diseases
Paraskevi Mantzana et al.
Summary: This study assessed the in vitro synergistic activity of antimicrobial combinations against carbapenem-resistant and colistin-resistant A. baumannii and K. pneumoniae, aiming to provide more treatment options for these infections. The tested antimicrobial combinations demonstrated high synergy rates, making them valuable options against A. baumannii and K. pneumoniae infections.
Article
Infectious Diseases
Ionela-Larisa Miftode et al.
Summary: This study aimed to assess the impact of COVID-19 on patients with carbapenem-resistant Enterobacterales (CRE) urinary tract infections (UTIs) and the trends in antibiotic resistance after the onset of the pandemic. The results showed that COVID-19 patients had worse outcomes, with significantly higher rates of ICU admissions and mortality. Additional risk factors associated with increased mortality included urinary catheterization, sepsis with K. pneumoniae, impaired liver and kidney function, and inappropriate initial empiric antibiotic therapy.
Article
Infectious Diseases
Yi-Yun Liu et al.
Summary: This study examined the synergy between colistin and capric acid against Gram-negative bacterial isolates, including both colistin-susceptible and colistin-resistant strains. The results showed a synergistic effect against all colistin-resistant strains and some colistin-susceptible strains, suggesting that the combination of colistin and capric acid is a promising therapeutic strategy against colistin-resistant Gram-negative infections.
Article
Communication
Mia Lindgren et al.
Summary: COVID-19 highlighted the importance of reliable and accessible health information, leading news organizations to increasingly adopt podcasting as a means to inform their audience. Podcasting's ability to engage listeners makes it a relevant medium to explore another global health threat, superbugs, through the lens of constructive journalism. This study investigates how constructive podcast journalism intersects with narrative podcasts, specifically in the context of antimicrobial resistance (AMR), finding that podcasting can empower individuals affected by AMR by providing them a platform to share empowering information rather than being portrayed solely as victims. This research contributes to the field of public health journalism by showcasing the impact of constructive podcasting in delivering solutions and promoting change.
MEDIA INTERNATIONAL AUSTRALIA
(2023)
Review
Infectious Diseases
Abdollah Ardebili et al.
Summary: The increasing prevalence of infections with multidrug-resistant (MDR), extensively-drug resistant (XDR) or difficult-to-treat (DTR) Gram-negative bacilli poses a severe challenge. Polymyxins, such as polymyxin B and colistin, have become a mainstay in clinical practices for treating these infections. However, the effect of polymyxin combination therapy versus monotherapy on treating Gram-negative bacilli-related infections is still unclear.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
(2023)
Article
Infectious Diseases
Kamini Walia et al.
Summary: COVID-19 demanded urgent global attention, during which antimicrobial resistance (AMR) increased silently, undermining patient safety. AMR is on the rise, especially in low-income and middle-income countries. The pandemic highlighted the fragility of health systems and forced governments and global agencies to think creatively.
LANCET INFECTIOUS DISEASES
(2023)
Review
Pharmacology & Pharmacy
Amer El-Ghali et al.
Summary: SUL-DUR is a novel beta-lactam-beta-lactamase inhibitor designed for the treatment of carbapenem-resistant Acinetobacter baumannii (CRAB) infections. The FDA's fast-track approval for SUL-DUR is pending after the completion of the phase III ATTACK trial, which showed that SUL-DUR was non-inferior to colistin with a better safety profile. With limited treatment options available, SUL-DUR holds promise for the treatment of CRAB infections.
Article
Multidisciplinary Sciences
Lucie Semenec et al.
Summary: This study characterizes the genomes of A. baumannii and K. pneumoniae strains co-isolated from a single human lung infection, and investigates their interactions through various assays. The findings shed light on their effects on antimicrobial resistance and virulence during co-infection.
NATURE COMMUNICATIONS
(2023)
Editorial Material
Engineering, Environmental
Manish Kumar et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY LETTERS
(2023)
Review
Public, Environmental & Occupational Health
Suriya Rehman
Summary: The COVID-19 pandemic caused by the SARS-COV-2 virus is a significant global health crisis, just like the Spanish influenza in the 20th century. While efforts are made to control the current pandemic, antimicrobial resistance (AMR) is overshadowed. However, during this pandemic, AMR to frontline antibiotics may pose fatal threats to bacterial and fungal infections during routine procedures. The global outbreak of COVID-19 also has important ramifications for the development of antimicrobial drug resistance.
JOURNAL OF INFECTION AND PUBLIC HEALTH
(2023)
Review
Multidisciplinary Sciences
Skylar L. Martin et al.
Summary: Neisseria gonorrhoeae poses a serious public health threat due to antibiotic resistance. Rapid molecular antimicrobial susceptibility tests (ASTs) can help tailor antibiotic therapy for treatment options. By using statistical methods and genomic data, genotype can be used to predict antibiotic susceptibility. This framework can be applied to other organisms for diagnostics development.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
(2023)
Article
Microbiology
Yi Zhang et al.
Summary: The combination of colistin and flufenamic acid (FFA) has synergistic activity against multidrug-resistant (MDR) Gram-negative bacteria. This combination treatment shows effective antibacterial and antibiofilm activities in vitro and improves the survival rates of infected larvae in animal models. It has the potential to be a promising therapeutic tool for combating MDR bacteria and improving patient outcomes.
MICROBIOLOGY SPECTRUM
(2023)
Article
Microbiology
Diletta Collalto et al.
Summary: Co-administration of colistin and clofoctol enhances the bactericidal effect of colistin and reduces the minimum inhibitory concentration (MIC) of colistin in resistant strains. This study suggests the potential development of inhaled clofoctol-colistin formulations for the treatment of difficult-to-treat airway infections caused by drug-resistant Gram-negative pathogens.
MICROBIOLOGY SPECTRUM
(2023)
Article
Microbiology
Munawr AL Quraini et al.
Summary: This study assessed the in vitro synergy of different antibiotics with fosfomycin in XDR and PDR Acinetobacter baumannii. The results showed that FOS-MEM and CL-MEM combinations have promising synergistic effects against A. baumannii, providing potential therapeutic options for the treatment of XDR and PDR infections.
Review
Microbiology
Miguel angel Loyola-Cruz et al.
Summary: The ESKAPE group poses a threat to public health and is closely associated with severe hospital infections and high mortality rates. These bacteria's presence in hospitals directly impacts the incidence of healthcare-associated coinfections during the SARS-CoV-2 pandemic. In recent years, these pathogens have demonstrated resistance to multiple antibiotics, and the presence of high-risk clones contributes to the global spread of resistance mechanisms. During the pandemic, these pathogens have been implicated in coinfections among critically ill COVID-19 patients. The aim of this review is to provide a comprehensive understanding of the main microorganisms within the ESKAPE group that are involved in coinfections among COVID-19 patients, focusing on antimicrobial resistance mechanisms, epidemiology, and high-risk clones.
Article
Microbiology
Alyona Lavrinenko et al.
Summary: Our study aimed to characterize the respiratory tract microbiota in patients with COVID-like pneumonia in Kazakhstan and analyze the differences between COVID-19 positive and negative groups. Sputum samples were collected from hospitalized patients, aged 18 and above, in three cities in Kazakhstan with high COVID-19 burden in July 2020. Isolates were identified using MALDI-TOF MS, and susceptibility testing was performed by disk diffusion. Statistical analysis was conducted using SPSS 26 and MedCalc 19. Among 209 pneumonia patients, 40% tested positive for SARS-CoV-2 by RT-PCR, and 46% had bacterial co-infections. The most common bacteria identified were Klebsiella pneumoniae (23%), Escherichia coli (12%), and Acinetobacter baumannii (11%). Notably, a high percentage of Klebsiella pneumoniae exhibited phenotypic evidence of extended-spectrum beta-lactamases, Acinetobacter baumannii showed resistance to beta-lactams, and E. coli strains had evidence of ESBL production and fluoroquinolone resistance. Patients with bacterial co-infections had a higher proportion of severe disease. The study highlights the importance of targeted antibiotics and effective infection control practices to prevent the spread of resistant nosocomial infections.
Article
Infectious Diseases
Sumanth Gandra et al.
Summary: This study retrospectively compared the microbiology data of blood, respiratory, and urine cultures from a community hospital in India and two community hospitals in the USA during the COVID-19 pandemic. The proportion of contaminated blood cultures and carbapenem-resistant organisms in respiratory and urine cultures increased significantly during the pandemic period. In the US hospitals, there was a significant increase in methicillin-resistant Staphylococcus aureus in blood cultures. Continuity of antimicrobial stewardship activities and better infection prevention measures are crucial to minimize antimicrobial resistance burden among COVID-19 patients.
Article
Infectious Diseases
Fraser Tull et al.
Summary: Australia, as a nation with low levels of AMR, is facing the erosion of its advantage. Therefore, a project was conducted to investigate modifiable human behaviors that could slow down the spread of AMR. The study identified twelve behaviors through a workshop with diverse interdisciplinary experts and assessed them based on participation, likelihood, and perceived impact. Four priority behaviors were identified, including not pressuring doctors for antibiotics and lobbying supermarkets to sell antibiotic-free meat.
Review
Infectious Diseases
Katarina Novovic et al.
Summary: A. baumannii is a clinically significant pathogen causing various nosocomial infections. Colistin, as a last-resort antibiotic, is used to treat multidrug-resistant A. baumannii infections. However, several mechanisms of colistin resistance in A. baumannii have been reported, including loss of LPS, modifications of target LPS, and efflux of colistin. In addition, widespread heteroresistance in A. baumannii contributes to colistin treatment failure. This review critically assesses the molecular mechanisms and global distribution of colistin-resistant strains in A. baumannii based on more than 50 experimental papers.
Article
Biology
German Matias Traglia et al.
Summary: This study compared two strains of A. baumannii, one isolated before the pandemic and the other from a COVID-19 patient. The genomes showed high similarity but had numerous unique genes associated with virulence and antimicrobial resistance. These differences may be due to adaptive evolution to SARS-CoV-2 infection.
Review
Infectious Diseases
Bradley J. Langford et al.
Summary: This article describes the impact of the COVID-19 pandemic on antimicrobial resistance (AMR), particularly in hospital settings for Gram-negative organisms. The study found that the absence of enhanced infection prevention and control and/or antimicrobial stewardship programs was associated with an increase in Gram-negative AMR. Therefore, strengthening infection prevention, antimicrobial stewardship, and AMR surveillance are necessary in the context of the COVID-19 pandemic.
CLINICAL MICROBIOLOGY AND INFECTION
(2023)
Article
Public, Environmental & Occupational Health
Gleyce Hellen de Almeida de Souza et al.
Summary: This study found that the incidence of secondary multidrug-resistant Gram-negative infection in patients with COVID-19 in Brazil is unclear. A case-control study identified factors associated with the acquisition of multidrug-resistant Gram-negative bacteria (MDR-GNB) in patients with and without COVID-19, and described the mortality rates and clinical features associated with unfavorable outcomes. Among the patients, 926 Gram-negative bacteria were isolated, with 504 being multidrug-resistant, and 73 patients with COVID-19 had secondary MDR-GNB infection. Factors associated with patients' COVID-19-MDR-GNB infections included obesity, heart failure, use of mechanical ventilation, urinary catheter, and previous use of beta-lactams. The study also found higher mortality rates in patients with COVID-19-MDR-GNB compared to the control groups.
JOURNAL OF INFECTION AND PUBLIC HEALTH
(2023)
Review
Microbiology
Omar Khaznadar et al.
Summary: Antimicrobial resistance (AMR) is an ongoing issue that existed before the COVID-19 pandemic. The pandemic has affected antimicrobial stewardship by diverting attention from AMR and contributing to excessive antibiotic usage and measures that have further escalated the AMR problem. Outpatient methods and COVID-19 testing have also inadvertently contributed to the spread of multidrug-resistant bacteria and hindered their detection. Efficient antimicrobial stewardship is crucial in future pandemic and non-pandemic states to promote responsible antibiotic use and minimize AMR.
MICROBIOLOGY RESEARCH
(2023)
Letter
Tropical Medicine
Yusuff Adebayo Adebisi et al.
Summary: Antimicrobial resistance (AMR) is a global health crisis that causes approximately 700,000 deaths annually and could lead to 10 million deaths by 2050. Marginalised populations are disproportionately affected due to barriers such as socioeconomic and ethnic disparities, limited healthcare access, and inadequate living conditions. A comprehensive and inclusive response is crucial to address this issue, including equitable access to antibiotics, improved living conditions, education, and policy changes. Ignoring marginalised populations in the fight against AMR is both morally and strategically flawed. This article critically examines this oversight and emphasizes the urgent need for comprehensive action.
TROPICAL MEDICINE AND HEALTH
(2023)
Review
Biotechnology & Applied Microbiology
Alicia Calvo-Villamanan et al.
Summary: Antimicrobial resistance is a serious threat in public health and requires a global approach. The lack of a shared mental model, responsibility, and education hampers efforts to slow down the emergency and spread of resistant infections. A multidisciplinary approach is proposed, which includes strategies from education and psychology to increase awareness and a comprehensive and solidaristic model to address this borderless problem.
INTERNATIONAL MICROBIOLOGY
(2023)
Review
Infectious Diseases
Bradley J. Langford et al.
Summary: Analysis of 171 studies revealed a 5.1% prevalence of bacterial co-infection and a 13.1% prevalence of secondary infection in patients with COVID-19. Factors such as ICU setting and mechanical ventilation were associated with higher risk of bacterial infection.
CLINICAL MICROBIOLOGY AND INFECTION
(2022)
Article
Infectious Diseases
Mical Paul et al.
Summary: These guidelines address the targeted antibiotic treatment of 3GCephRE and carbapenem-resistant Gram-negative bacteria, focusing on the effectiveness of individual antibiotics and on combination versus monotherapy. Most recommendations are based on low-certainty evidence.
CLINICAL MICROBIOLOGY AND INFECTION
(2022)
Letter
Public, Environmental & Occupational Health
Kovy Arteaga-Livias et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
(2022)
Review
Infectious Diseases
Yu-Lin Lee et al.
Summary: The increasing carbapenem resistance in Enterobacterales is a threat to public health, mainly caused by the global dissemination of carbapenemase-producing Enterobacterales (CPE). Although certain traditional antibiotics may still be effective against some CPE, their use is limited due to adverse effects or the need for combination treatment. Several novel agents have been approved for clinical use, but their efficacy varies depending on the mechanisms associated with carbapenem resistance. Therefore, accurate and rapid diagnosis of CPE infection is crucial, along with determining their antimicrobial resistance mechanisms.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
(2022)
Article
Infectious Diseases
Marco Falcone et al.
Summary: From November 2020 to March 2021, hvKp was isolated in 36 COVID-19 patients, with 80.6% developing infections including bloodstream infections, ventilator-associated pneumonias, and complicated urinary tract infections. The majority of infections were caused by ST147 strains carrying multiple resistance genes. The 30-day mortality rate among infected patients was 48.3%.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
(2022)
Article
Infectious Diseases
John Merlino et al.
Summary: In Australia, the overuse or inappropriate prescribing of antimicrobials has become a growing concern, leading to increased resistance among bacteria, fungi, parasites, and viruses. While appropriate use of antimicrobials is life-saving, monitoring and addressing inappropriate use is crucial to improve the safety and quality of care. This report reviews and summarizes the efforts made in Australia to control antimicrobial resistance and promote responsible antibiotic prescribing.
MICROBIAL DRUG RESISTANCE
(2022)
Review
Biochemistry & Molecular Biology
Alessia Catalano et al.
Summary: Multidrug resistance, including resistance to anticancer agents and antimicrobial drugs, is a significant concern in public health. The widespread use of antibiotics has led to the emergence of pathogenic bacteria resistant to multiple drugs, and the ongoing COVID-19 pandemic may worsen antimicrobial resistance. Nanodrug delivery systems have shown promise in overcoming resistance.
Review
Environmental Sciences
Sidra Ghazali Rizvi et al.
Summary: Antimicrobial resistance is becoming a serious concern due to overuse of antibiotics, exacerbated by the increase in global antibiotic usage during the COVID-19 pandemic. This has led to higher concentrations of residual antibiotics in wastewater, posing a threat to natural water bodies. Urgent measures are needed to curb antibiotic usage and improve wastewater treatment to efficiently remove residual contaminants.
SCIENCE OF THE TOTAL ENVIRONMENT
(2022)
Article
Environmental Sciences
Reshma Silvester et al.
Summary: The global emergence of multi-drug resistant and hypervirulent strains of Klebsiella pneumoniae poses significant challenges to current treatment strategies and public health management in Low-and Middle-Income Countries. Regular surveillance and necessary interventions are strongly recommended to address this critical issue.
SCIENCE OF THE TOTAL ENVIRONMENT
(2022)
Editorial Material
Biochemistry & Molecular Biology
Clemence Whiteway et al.
TRENDS IN MICROBIOLOGY
(2022)
Review
Virology
Nannan Wu et al.
Summary: With over 200 million people affected and 4.5 million dead, the COVID-19 pandemic has become one of the greatest disasters in human history. Secondary bacterial infections (SBIs) are known complications of viral respiratory infections, and antibiotic treatments often fail to cure the patients. Phages, as natural killers of bacteria, are considered promising alternatives to antibiotics for treating pulmonary bacterial infections. However, their use for treating SBIs during virus pandemics like COVID-19 is still not well understood.
CURRENT OPINION IN VIROLOGY
(2022)
Article
Public, Environmental & Occupational Health
Anne Harant
Summary: Most African countries have national action plans on antimicrobial resistance (AMR) publicly available, but lack transparency in terms of surveillance data, funding allocations, and progress reports. Information on bodies responsible for implementation of NAPs is often unclear, and accountability for AMR results is weak. Concrete policy recommendations are provided to improve transparency and accountability for curbing AMR effectively.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL
(2022)
Article
Public, Environmental & Occupational Health
Renato Pascale et al.
Summary: This study assessed the incidence of colonization and infection with CPE and CR-Ab in ICUs before and during the COVID-19 pandemic. The results showed no significant change in CPE colonization and infection, but a significant increase in CR-Ab colonization and infection. The CR-Ab strains belonged to the same clonal lineage and horizontal transmission was observed. Therefore, infection control activities should be conducted during the pandemic and adjusted according to the situation.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
(2022)
Article
Infectious Diseases
Jayaseelan Murugaiyan et al.
Summary: This review explores the development of new antimicrobial drugs and alternative strategies to traditional antibiotics. Various alternative approaches, including combination therapy, techniques targeting antimicrobial resistance enzymes or proteins, drug delivery systems, etc., are proposed as potential solutions.
Article
Infectious Diseases
Naveed Ahmed et al.
Summary: This study investigated the prevalence of bacterial co-infections and antimicrobial resistance (AMR) in hospitalized COVID-19 patients in Lahore, Pakistan. The results showed a significant association between bacterial co-infections and hospitalized COVID-19 patients, with many bacteria showing high resistance to common antibiotics. Additionally, common symptoms of COVID-19 patients were significantly associated with bacterial co-infections. The findings highlight the potential severity of AMR and emphasize the importance of strict adherence to antibiotic usage guidelines and implementation of antibiotic stewardship programs at all institutional levels.
Article
Medicine, General & Internal
Sushma Yadav Boorgula et al.
Summary: This study aims to determine the prevalence of bacterial and fungal coinfections in COVID-19 patients and assess the antimicrobial resistance patterns in the obtained isolates. The results of the study show that these secondary infections are more common in patients aged over 40, with Klebsiella pneumoniae being the most common pathogen in respiratory samples. Additionally, there was an overall increase in Carbapenem resistance in the isolates.
JOURNAL OF LABORATORY PHYSICIANS
(2022)
Article
Pharmacology & Pharmacy
Gouri Rani Banik et al.
Summary: This systematic review aimed to investigate the impact of prolonged use of antimicrobial hand hygiene products on antimicrobial resistance (AMR). The results showed that prolonged use of these products may lead to AMR in healthcare settings, but not necessarily in other settings.
Article
Immunology
Sharon Ong'uti et al.
Summary: Cefiderocol, a novel injectable siderophore cephalosporin, is effective against multidrug-resistant gram-negative bacteria by hijacking the bacterial iron transport system. It has broad-spectrum antibacterial activity, including against carbapenem-resistant and Acinetobacter baumannii strains.
CLINICAL INFECTIOUS DISEASES
(2022)
Article
Infectious Diseases
Alessandro Russo et al.
Summary: Our study found that COVID-19 patients exhibited higher occurrences of serum lactate levels mmol/l > 2, Acinetobacter baumannii colonization, BSI, and steroid therapy. Cox regression analysis demonstrated that serum lactate levels > 2 mmol/l, Acinetobacter baumannii colonization, BSI, and steroid therapy were associated with 30-day mortality. Additionally, factors independently associated with the development of BSI in COVID-19 patients included white blood cells count > 11,000 mm(3), serum lactate levels > 2 mmol/l, infections at time of ICU admission, Acinetobacter baumannii colonization, and steroid therapy.
Meeting Abstract
Infectious Diseases
I. Lambraki et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2022)
Article
Infectious Diseases
Akane Ono et al.
Summary: The study found that the COVID-19 pandemic had a significant impact on antimicrobial use trends in Japan in 2020, resulting in a substantial reduction in AU. This reduction may be partly attributed to the pandemic itself and recent efforts to improve AU. Therefore, continued surveillance and research on antimicrobial use are necessary.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2022)
Review
Virology
Domenico Iacopetta et al.
Summary: The COVID-19 pandemic caused by the SARS-CoV-2 virus poses a severe threat to public health. The search for vaccines has led to the approval of about twenty COVID-19 vaccines, but new genetic mutations and variants continue to emerge, necessitating pharmacological treatments.Various treatments, including antivirals, antibiotics, immunomodulators, vitamins, and drug repositioning, are being used to combat the spread of the virus.
Review
Public, Environmental & Occupational Health
Ruwandi M. Kariyawasam et al.
Summary: This study conducted a systematic review and meta-analysis to investigate the prevalence and types of resistant co-infecting organisms in COVID-19 patients. The results showed a high prevalence of antimicrobial resistance (AMR) in these patients, with variations across different hospitals and geographic settings. This finding is crucial for improving global surveillance programs, infection prevention and control measures, and antimicrobial stewardship programs.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL
(2022)
Article
Public, Environmental & Occupational Health
Marco Floridia et al.
Summary: Secondary infections are more common than co-infections in hospitalized patients with severe COVID-19, and are mainly caused by Gram-negative bacterial pathogens that show a very high rate of antibiotic resistance.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL
(2022)
Article
Microbiology
Francesca Serapide et al.
Summary: The study compared the prevalence of ESKAPE multidrug-resistant bacterial infections between COVID-19 affected and unaffected patients, and found a higher frequency of MDR ESKAPE bacteria in COVID-19 patients admitted to the ICU. Acinetobacter baumannii was identified as the main pathogen in COVID-19 patients and was associated with a higher mortality rate, highlighting the importance of infection control measures in combating antimicrobial resistance.
Article
Infectious Diseases
Pami Shrestha et al.
Summary: This study aimed to identify and understand the challenges and opportunities for collaborative antimicrobial resistance (AMR) research in Asia. Factors influencing research collaborations were found to be the multi-dimensional nature of AMR, limited funds, different AMR research priorities in Asian countries, absence of Asia-centric AMR leadership, lack of trust and unequal power relationships between researchers, and the negative impact of the COVID-19 pandemic. The study also highlighted opportunities such as researchers' willingness to collaborate, the formation of networks, and the prioritization of the One Health paradigm for AMR research.
Review
Infectious Diseases
Paolo Gaibani et al.
Summary: Multidrug resistance (MDR) is a serious global threat due to the rapid spread of MDR pathogens and limited treatment options. New beta-lactams/beta-lactamase inhibitor combinations (beta L-beta LICs) have shown promise for treating MDR Gram-negative infections. However, resistance to these novel molecules has started to emerge. This review summarizes the mechanisms of resistance to ceftazidime/avibactam, meropenem/vaborbactam, and imipenem/relebactam in MDR Gram-negative microorganisms, with a focus on antimicrobial activities and resistance traits related to novel beta L-PLICs. The detection methods for antimicrobial susceptibility testing of these molecules are also discussed.
Review
Infectious Diseases
Maria Stefania Sinicropi et al.
Summary: Triclosan (TCS) is a widely used broad-spectrum antimicrobial agent in personal care products. Its toxicity to mammals and the adverse effects of long-term exposure are still unclear. Recent reports suggest its potential use in cancer treatment and cutaneous leishmaniasis.
Article
Infectious Diseases
Timothy Jesudason
LANCET INFECTIOUS DISEASES
(2022)
Review
Biochemistry & Molecular Biology
Jessica Ceramella et al.
Summary: This review provides an overview of the current pharmacological therapies used for the treatment of COVID-19, highlighting the ongoing need for more effective vaccines, therapies, and other solutions.
Article
Microbiology
J. Nicholas O'Donnell et al.
Summary: Imipenem/cilastatin/relebactam is a novel combination medication with expanded activity against carbapenem-resistant non-Morganellaceae Enterobacterales and difficult-to-treat Pseudomonas aeruginosa. It has been approved for the treatment of certain bacterial infections when alternative treatments are limited. Further research is needed to determine its optimal role in treating highly resistant Gram-negative infections.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2022)
Article
Public, Environmental & Occupational Health
Aaron Lapuz Alejandro et al.
Summary: This study examines the local factors influencing parents' responsible use of antibiotics for children in Perth. The results show that while parents have awareness of the indications of antibiotics, they lack understanding of antimicrobial resistance (AMR) and tend to overvalue antibiotics. It is suggested that promoting parent empowerment and participation in decision-making, as well as maintaining a positive relationship with healthcare providers, are important strategies to encourage appropriate antibiotic use.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
(2022)
Review
Infectious Diseases
Giulia Jole Burastero et al.
Summary: Ventilator-associated pneumonia (VAP) is a major threat in critically ill COVID-19 patients, with a higher incidence rate and significant mortality. Pseudomonas aeruginosa is the most common pathogen, but other uncommon gram-negative bacteria such as Burkholderia cepacea and Stenotrophomonas maltophilia have also emerged. Ceftazidime/avibactam (CZA) is considered an effective treatment option, especially for carbapenem-resistant microorganisms. This report describes the use of CZA in a case series of COVID-19 patients with VAP caused by difficult-to-treat (DTT) gram-negative bacteria, including uncommon pathogens like Burkholderia cepacea and Stenotrophomonas maltophilia.
Article
Infectious Diseases
Francesco Cogliati Dezza et al.
Summary: This study evaluates the impact of COVID-19 on MDR-GN bloodstream infections in an ICU setting. The study finds that COVID-19 patients have a higher incidence of MDR-GN infections and experience more severe conditions and higher mortality rates.
Article
Medicine, General & Internal
Nicolo Brandi et al.
Summary: Bacterial and fungal co-infections and superinfections are frequent in COVID-19 patients admitted to the ICU and are associated with worse outcomes. Imaging plays an important role in monitoring critically ill COVID-19 patients and may help detect these complications, suggesting further laboratory investigations.
Editorial Material
Infectious Diseases
Jay Patel et al.
Review
Microbiology
Z. S. Khankhel et al.
Summary: Bloodstream infections, especially those caused by resistant pathogens, present significant challenges in management. This systematic literature review examines the utilization of ceftolozane/tazobactam in bacteremia and suggests that it may be beneficial in improving outcomes. However, the limited data and high heterogeneity call for further research to understand the exact effects of this treatment.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
(2022)
Review
Environmental Sciences
Hadi Jaber Al Sulayyim et al.
Summary: This study explored the impact of the COVID-19 pandemic on antibiotic resistance (AR) and found that AR has increased during this period. Gram-negative bacteria such as Acinetobacter baumannii and Klebsiella pneumoniae showed high resistance to tested antibiotics, while Gram-positive bacteria like Staphylococcus aureus and Enterococcus faecium exhibited resistance to certain antibiotics. Risk factors for high levels of AR during COVID-19 included self-antibiotic medication, empirical antibiotic administration, and antibiotics prescribed by general practitioners.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2022)
Article
Microbiology
Edwin Kamau et al.
Summary: The study found that hypervirulent Klebsiella pneumoniae infections were more common than expected in Southern California, presenting with various symptoms, occasionally mimicking tumors, and even co-infecting a COVID-19 patient. Genomic analysis showed genetic diversity, underscoring the importance of heightened awareness, rapid diagnosis, and robust surveillance programs for hvKp infections.
FRONTIERS IN MICROBIOLOGY
(2022)
Review
Infectious Diseases
Genesy Perez Jorge et al.
Summary: This review discusses the misuse of antibiotics in patients with COVID-19 and its impact on the spread of multidrug-resistant bacteria. The study found that bacterial infections are relatively rare in COVID-19 patients, yet most of these patients still receive antibiotic treatments. The review highlights factors such as overprescription of antibiotics, self-medication, and lack of adequate diagnostic tests that contribute to inappropriate antibiotic use and the increase in antibiotic resistance. Strengthening epidemiological surveillance of hospital isolates and improving antibiotic prescribing are crucial.
CURRENT INFECTIOUS DISEASE REPORTS
(2022)
Article
Infectious Diseases
Jeniffer Munyiva Mutua et al.
Summary: This study evaluated the etiologies, antimicrobial resistance profiles, risk factors, and outcomes of bacterial infections in severely ill COVID-19 patients. The study found that at least 44.2% of the sampled patients had bacterial infections, with multidrug-resistant strains being predominant and males being more susceptible to bacterial infection. Elderly patients, non-SARS-CoV-2 vaccination, intensive care unit admission, and long hospital stays were associated with poor outcomes.
BMC INFECTIOUS DISEASES
(2022)
Article
Medicine, General & Internal
Osman Karabay et al.
Summary: This study investigated the antibiotic resistance profiles of A. baumannii strains isolated from different clinics of a hospital and identified the class D beta-lactamase resistance genes causing carbapenem resistance. The results showed that colistin, tigecycline, and amikacin were the most effective antibiotics for carbapenem-resistant A. baumannii isolates. The prevalence of the OXA-24 enzyme gene was higher in this study compared to other similar studies.
EUROPEAN JOURNAL OF THERAPEUTICS
(2022)
Article
Medicine, Research & Experimental
Raspail C. Founou et al.
Summary: The COVID-19 pandemic has led to widespread misuse of antibiotics, which is likely to significantly increase antimicrobial resistance globally. Decision-makers need to consider the hidden threat of antimicrobial resistance, exacerbated by improper antibiotic use in treating severe COVID-19 patients, in addition to the expanding COVID-19 pandemic.
Article
Infectious Diseases
Clark D. Russell et al.
Summary: Microbiologically confirmed bacterial infections are rare in patients admitted with COVID-19, mostly being secondary infections. Gram-negative organisms and S aureus are the predominant pathogens. Antimicrobial use is frequent, but can be intervened with stewardship measures.
Article
Medicine, General & Internal
Massimo Sartelli
BANGLADESH JOURNAL OF MEDICAL SCIENCE
(2021)
Review
Infectious Diseases
Bradley J. Langford et al.
Summary: The study estimated that approximately three-quarters of patients with COVID-19 receive antibiotic treatment, which is significantly higher than the estimated prevalence of bacterial co-infection. This suggests a potential for high rates of unnecessary antibiotic use in patients with COVID-19.
CLINICAL MICROBIOLOGY AND INFECTION
(2021)
Article
Infectious Diseases
Tekle Airgecho Lobie et al.
Summary: Exposure of microbes to pharmaceutical and non-pharmaceutical agents contributes to antibiotic resistance development, and the risks and consequences of extensive disinfectant use during the COVID-19 pandemic are still unclear. Some disinfectants contain genotoxic chemicals that damage microbial DNA, leading to mutations that induce antimicrobial resistance. Additionally, restricted access to health services due to COVID-19 precautions poses challenges for the study of antimicrobial resistance.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Public, Environmental & Occupational Health
Hyacinth O. Ukuhor
Summary: The COVID-19 pandemic has resulted in high morbidity and mortality rates, with some cases showing resistance to antimicrobials leading to worse outcomes. Antimicrobial-resistant co-infections have been a significant factor in clinically significant mortality. Various factors such as misuse of antimicrobials, international travel, healthcare financing issues, human use/misuse, agricultural production, and climate change are determinants of antimicrobial resistance.
JOURNAL OF INFECTION AND PUBLIC HEALTH
(2021)
Article
Infectious Diseases
Emilio Mariano Duran-Manuel et al.
Summary: The study identified and characterized the distribution and clonal spread of ESKAPE bacteria in medical devices, patients, and medical personnel in the ICU for COVID-19 patients at Hospital Juarez de Mexico. Acinetobacter baumannii and Staphylococcus aureus were the predominant ESKAPE members, with clonal spread of A. baumannii (AdeABCRS+) emphasizing the importance of implementing proper disinfection practices and management for COVID-19 patients.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
(2021)
Review
Biology
Gwenan M. Knight et al.
Summary: The impact of the COVID-19 pandemic on antimicrobial resistance is two-fold, potentially reducing resistance through increased hand hygiene and decreased international travel, but also exacerbating it through increased antibiotic use. The dynamics of antimicrobial resistance remain uncertain at this stage, highlighting the need for global collaboration to address this intersecting public health challenge.
Review
Virology
Francesco Vladimiro Segala et al.
Summary: The COVID-19 pandemic has led to a significant disruption of healthcare systems and practices, resulting in a high incidence of infections caused by multidrug-resistant pathogens. Inappropriate antimicrobial exposure and discontinuation of infection control measures may have contributed to the selection and spread of drug-resistant bacteria and fungi.
Review
Infectious Diseases
Peng Lan et al.
Summary: Hypervirulence and carbapenem resistance have emerged as two distinct evolutionary directions for Klebsiella pneumoniae, posing a great threat in clinical settings. CR-hvKP strains, integrating both phenotypes, have become increasingly prevalent globally, primarily in Asia. The mechanisms for the emergence of CR-hvKP can be summarised by three patterns, and continued surveillance of their dissemination should be highly prioritised.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
(2021)
Review
Multidisciplinary Sciences
Andrew R. Mahoney et al.
Summary: The importance of rapid development of vaccines and antivirals due to the ongoing SARS-CoV-2 pandemic has been highlighted, but the increased use of antibacterial products and treatments poses an underreported threat of antibiotic resistances emergence.
Review
Microbiology
De Chang et al.
Summary: Klebsiella species can cause infections at multiple sites, with a higher likelihood in individuals with preexisting health conditions. Klebsiella pneumoniae has become a major international pathogen due to the rise of hypervirulent and carbapenem-resistant strains. Understanding risk factors, prevention strategies, and treatment options is crucial in combating multidrug-resistant Klebsiella infections.
FRONTIERS IN MICROBIOLOGY
(2021)
Article
Immunology
Pranita D. Tamma et al.
Summary: This guidance document provides recommendations for the treatment of antimicrobial-resistant infections commonly encountered in US hospitals, focusing on ESBL-E, CRE, and DTR-P. aeruginosa. It includes preferred and alternative treatment recommendations, discussion on empiric treatment selection and management considerations, and will be periodically updated. The current version is as of 17 September 2020, with plans to expand recommendations to include other problematic gram-negative pathogens in future versions.
CLINICAL INFECTIOUS DISEASES
(2021)
Review
Microbiology
Giuseppe Mancuso et al.
Summary: Overuse and misuse of antibiotics have accelerated the spread of antibiotic-resistant bacteria, leading to at least 700,000 deaths worldwide each year. Without new treatments, this number could rise to 10 million by 2050, posing a serious global health threat.
Review
Biochemistry & Molecular Biology
Domenico Iacopetta et al.
Summary: Triclocarban, a polychlorinated aromatic antimicrobial agent, has been widely used in various products for over 50 years, but concerns about its endocrine disruptive properties have led to a ban by the U.S. Food and Drug Administration in hand and body washes. Efforts are now being made to find alternative antimicrobial compounds.
Review
Biochemistry & Molecular Biology
Lars F. Westblade et al.
Summary: Bacterial coinfections are not common in patients with COVID-19 upon admission, but may frequently occur during hospitalization. Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae are common pathogens. Most patients hospitalized with COVID-19 do not need antibacterial therapy and diagnostic testing for bacterial infections upon admission, but clinicians should be vigilant for nosocomial infections.
TRENDS IN MICROBIOLOGY
(2021)
Article
Infectious Diseases
Ahmad Sleiman et al.
Summary: This study characterized two carbapenem-resistant K. pneumoniae strains from the same patient, revealing a high number of antimicrobial resistant genes and virulence factor genes which could potentially lead to life-threatening infections.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
(2021)
Review
Medicine, General & Internal
Wioletta Medrzycka-Dabrowska et al.
Summary: The study highlights the importance of paying attention to carbapenem-resistant Klebsiella pneumoniae infections in patients with COVID-19. Rational antibiotic therapy should be used to prevent the increase of bacterial resistance, along with continuous monitoring and surveillance of hospital infections caused by multidrug-resistant organisms.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Infectious Diseases
Sara Tomczyk et al.
Summary: The survey on the global impact of COVID-19 on AMR among GLASS countries revealed reduced availability of healthcare and cleaning staff, which could bias AMR surveillance data. Additionally, most countries still lack complete data to measure the specific impact of COVID-19 on AMR rates.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
(2021)
Review
Biochemistry & Molecular Biology
Susan Ibrahim et al.
Summary: Acinetobacter baumannii has become a major concern in the scientific community due to its extensive antimicrobial resistance. The acquisition of mobile genetic elements has led to the prevalence of multidrug-resistant strains, including carbapenem-resistant A. baumannii (CR-Ab), which is a worldwide problem. Plasmid-mediated resistance has caused outbreaks of extensively drug-resistant A. baumannii (XDR-Ab), highlighting the importance of proper monitoring, prevention, and treatment to control infections.
MOLECULAR BIOLOGY REPORTS
(2021)
Article
Microbiology
Marina Gysin et al.
Summary: Considerable levels of antimicrobial resistance may contribute to bacterial superinfections in ventilated COVID-19 patients, requiring consecutive adaptation of antibiotic therapy. High susceptibility to amikacin and apramycin indicates that aminoglycosides can be effective second-line treatments for ventilator-associated bacterial pneumonia, with effective drug exposure in the lungs being crucial. Genotypic analysis of Pseudomonas aeruginosa isolates revealed a frameshift mutation in the transcriptional regulator nalC associated with a change in susceptibility to beta-lactams and quinolones.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
(2021)
Review
Environmental Sciences
Luisa Toro-Alzate et al.
Summary: Social sciences play a crucial role in combating antimicrobial resistance and COVID-19 by addressing social issues such as changes in antibiotic prescription behavior and misinformation control. Effective interventions can help mitigate the impact of these public health challenges.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2021)
Review
Microbiology
Karyne Rangel et al.
Summary: The COVID-19 pandemic has led to overuse of antimicrobials in critically ill patients, increasing the incidence of pathogens like Acinetobacter baumannii in ICUs. Patients with COVID-19 are at risk of secondary bacterial infections due to comorbidities and immune dysfunction.
Article
Infectious Diseases
Vikas Saini et al.
Summary: The study explored the antimicrobial resistance pattern of bacterial agents isolated from COVID-19 patients and found an increase in AMR among isolates obtained during the pandemic compared to pre-COVID-19 times. The overuse of antibiotics created opportunities for bacterial pathogens to develop resistance mechanisms, highlighting the need for proper antibiotic use and infection control practices to combat AMR effectively.
Article
Infectious Diseases
Shamshul Ansari et al.
Summary: The COVID-19 pandemic poses a potential impact on global antimicrobial resistance, with critically ill patients possibly leading to overuse of antibiotics and mild cases also potentially misusing antibiotics. There is a need for increased awareness of antimicrobial resistance, proper antibiotic use, and strengthening of infection control and diagnostics.
JAC-ANTIMICROBIAL RESISTANCE
(2021)
Letter
Tropical Medicine
Yusuff Adebayo Adebisi et al.
Summary: Antimicrobial resistance poses a hidden threat exacerbated by the widespread and unnecessary use of antibiotics, leading to the emergence and spread of resistant pathogens. Despite COVID-19 being a viral disease, various antibiotics are recommended for use in the management of the disease in African countries, highlighting the need for prudent and judicious use of antibiotics.
TROPICAL MEDICINE AND HEALTH
(2021)
Article
Infectious Diseases
Sonam Vijay et al.
Summary: A study in India found that 3.6% of hospitalized COVID-19 patients developed secondary bacterial or fungal infections, with a mortality rate of 56.7% among those with secondary infections.
INFECTION AND DRUG RESISTANCE
(2021)
Article
Immunology
Tomohiro Hosoda et al.
Summary: In patients with coronavirus disease who deteriorate rapidly, co-infections by bacterial and fungal pathogens, including hypervirulent Klebsiella pneumoniae in eastern Asia, should be considered in the differential diagnosis.
EMERGING INFECTIOUS DISEASES
(2021)
Review
Medicine, General & Internal
J. E. Choby et al.
JOURNAL OF INTERNAL MEDICINE
(2020)
Article
Biochemistry & Molecular Biology
Weihua Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2020)
Editorial Material
Microbiology
Alexander J. McAdam
JOURNAL OF CLINICAL MICROBIOLOGY
(2020)
Editorial Material
Medicine, General & Internal
Marie-Stephanie Aschtgen et al.
JOURNAL OF INTERNAL MEDICINE
(2020)
Review
Infectious Diseases
Ramanan Laxminarayan et al.
LANCET INFECTIOUS DISEASES
(2020)
Article
Microbiology
Viviana Cafiso et al.
FRONTIERS IN MICROBIOLOGY
(2020)
Review
Infectious Diseases
Andrea Novelli et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
(2020)
Review
Chemistry, Multidisciplinary
Yu-Xuan Ma et al.
Article
Public, Environmental & Occupational Health
Sara Kotb et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL
(2020)
Editorial Material
Medicine, General & Internal
Joost Hopman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2020)
Editorial Material
Infectious Diseases
Timothy M. Rawson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
(2020)
Review
Infectious Diseases
Louise Lansbury et al.
JOURNAL OF INFECTION
(2020)
Review
Immunology
Chih-Cheng Lai et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
(2020)
Editorial Material
Microbiology
Aimee K. Murray
FRONTIERS IN MICROBIOLOGY
(2020)
Review
Infectious Diseases
Pourya Gholizadeh et al.
INFECTION AND DRUG RESISTANCE
(2020)
Review
Infectious Diseases
Bradley J. Langford et al.
CLINICAL MICROBIOLOGY AND INFECTION
(2020)
Editorial Material
Public, Environmental & Occupational Health
Haileyesus Getahun et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION
(2020)
Article
Immunology
Yiqi Fu et al.
OPEN FORUM INFECTIOUS DISEASES
(2020)
Article
Virology
Guqin Zhang et al.
JOURNAL OF CLINICAL VIROLOGY
(2020)
Editorial Material
Medicine, General & Internal
Steffanie A. Strathdee et al.
Editorial Material
Multidisciplinary Sciences
Moustapha Mbow et al.
Article
Infectious Diseases
Paul G. Higgins et al.
Article
Public, Environmental & Occupational Health
Stephen Perez et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
(2020)
Article
Immunology
Chao Liu et al.
Letter
Infectious Diseases
Michael J. Cox et al.
Article
Critical Care Medicine
Wasan Katip et al.
JOURNAL OF INTENSIVE CARE MEDICINE
(2019)
Review
Microbiology
Thomas A. Russo et al.
CLINICAL MICROBIOLOGY REVIEWS
(2019)
Review
Microbiology
Mansura S. Mulani et al.
FRONTIERS IN MICROBIOLOGY
(2019)
Review
Infectious Diseases
Young Ran Lee et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
(2019)
Review
Infectious Diseases
Adrian J. Brink
CURRENT OPINION IN INFECTIOUS DISEASES
(2019)
Article
Immunology
Yohei Doi
CLINICAL INFECTIOUS DISEASES
(2019)
Editorial Material
Infectious Diseases
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES
(2019)
Review
Pharmacology & Pharmacy
Kristy M. Shaeer et al.
Article
Microbiology
Chaitra Shankar et al.
Article
Microbiology
Jane F. Turton et al.
JOURNAL OF MEDICAL MICROBIOLOGY
(2018)
Article
Microbiology
Cedric Rafat et al.
JOURNAL OF MEDICAL MICROBIOLOGY
(2018)
Article
Infectious Diseases
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES
(2018)
Review
Immunology
Rebekah M. Martin et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2018)
Article
Ophthalmology
Capucine Odouard et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
(2017)
Article
Infectious Diseases
Okechukwu Mgbemena et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2017)
News Item
Multidisciplinary Sciences
Cassandra Willyard
Review
Immunology
Juan Carlos Catalan-Najera et al.
Article
Microbiology
Anna Giammanco et al.
Article
Microbiology
Andrea M. Hujer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2017)
Article
Infectious Diseases
A. Nutman et al.
CLINICAL MICROBIOLOGY AND INFECTION
(2016)
Review
Microbiology
Michelle K. Paczosa et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
(2016)
Review
Microbiology
Bei Li et al.
FUTURE MICROBIOLOGY
(2014)
Article
Public, Environmental & Occupational Health
Clare Rock et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
(2014)
Review
Infectious Diseases
L. Kristopher Siu et al.
LANCET INFECTIOUS DISEASES
(2012)
Article
Public, Environmental & Occupational Health
Michelle Doidge et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
(2010)
Article
Medicine, General & Internal
Clinton K. Murray et al.
Article
Gastroenterology & Hepatology
ER Lederman et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY
(2005)
Review
Infectious Diseases
GA Pankey
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
(2005)
Review
Infectious Diseases
P Nordmann et al.
CLINICAL MICROBIOLOGY AND INFECTION
(2002)
